Is the bed capture enzyme immunoassay useful for surveillance in concentrated epidemics? The case of female sex workers in Indonesia

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 3, 2011, Pages 634-642

  Morineau, Guy ^a   Magnani, Robert ^a   Nurhayati, Agus ^a   Bollen, Liesbeth ^a   Mustikawati, Dyah Erti ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b MINISTRY OF HEALTH   (Indonesia)

Author keywords

Bed assay; Concentrated epidemics; Female sex workers; Hiv incidence; Indonesia; Surveillance

Indexed keywords

EID: 79961086791     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barin F, Meyer L, Lancar R, et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spotsJ Clin Microbiol 2005; 43: 4441-7. (Pubitemid 41298225)
2. Bärnighausen T, Wallrauch C, Weite A, et al. HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional BED assay testingPLoS One 2008; 3: e3640.
3. Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect 2004; 80 (suppl 1):i19-24. (Pubitemid 39070780)
4. Buchacz K, Klausner JD, Kerndt PR, et al. HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005J Acquir Immune Defic Syndr 2008; 47: 234-40. (Pubitemid 351172192)
5. Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted? AIDS 2009; 23: 485-91.
6. Chawla A, Murphy G, Donnelly C, et al. Human immunodeficiency virus HIV antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 HIV-1-seropositive persons infected with diverse HIV-1 subtypesJ Clin Microbiol 2007; 45: 415-20.
7. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS. Performance characteristics of the immunoglobulin G-capture BEDenzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J CZi'n Microbiol 2004; 42: 2623-8. (Pubitemid 38747513)
8. Foley B, Donegan E, Silitonga N, Wignall FS, Busch MP, Delwart EL. Importation of multiple HIV type 1 strains into West Papua, Indonesia Irian JayaAIDS Res Hum Retroviruses 2001; 17: 1655-9. (Pubitemid 34072821)
9. Hallett T, Garnett G. Estimating incidence of HIV infection in UgandaJAMA 2009; 14; 301: 159.
10. Hargrove JW, Humphrey JH, Mutasa K, et al. Improved HIV-1 incidence estimates using the BED capture enzyme immunoassayAIDS 2008; 22: 511-8. (Pubitemid 351317293)
11. Hu DJ, Vanichseni S, Mock PA, et al. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassayAIDS Res Hum Retroviruses 2003; 19: 727-30. (Pubitemid 37215127)
12. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposesJAMA 1998; 280: 42-8. (Pubitemid 28414995)
13. Jiang Y, Wang M, Ni M, et al. HIV-1 incidence estimates using IgG-capture BED-enzyme immunoassay from surveillance sites of injection drug users in three cities of China. AIDS 2007; 21 (suppl 8): S47-51.
14. Karita E, Price M, Hunter E, et al. IAVI Collaborative Seroprevalence and Incidence Study Team. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007; 21: 403-8.
15. Kartikeyan S, Bharmal RN, Tiwari RP, Bise PS. Natural history of HIV infection. In: Kartikeyan S, Bharmal RN, Tiwari RP, Bise PS, eds. HIV and AIDS: basic elements and priorities. New York: Springer Verlag, 2007; 79-83.
16. Killian MS, Norris PJ, Rawal BD, et al. The effects of early antiretroviral therapy and its discontinuation on the HIV-specific anti-body responseAIDS Res Hum Retroviruses 2006; 22: 640-7. (Pubitemid 44061400)
17. Kothe D, Byers RH, Caudill SP, et al. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidenceJ Acquir Immune Defic Syndr 2003; 33: 625-34. (Pubitemid 36975851)
18. Lakshmi V, Sudha T, Dandona R, Teja VD, Kumar GA, Dandona L. Application of human immunodeficiency virus type 1 BED enzyme immunoassay on dried blood spots in IndiaJ Med Microbiol 2009; 58 Pt 3: 312-7.
19. McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006; 22: 945-52. (Pubitemid 46100678)
20. Mc Dougal JC. BED estimates of HIV incidence must be adjustedAIDS 2009; 23: 2064-5.
21. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in UgandaJAMA 2008; 300: 540-9.
22. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidenceAIDS Res Hum Retroviruses 2002; 18: 295-307. (Pubitemid 34253148)
23. Rawal BD, Degula A, Lebedeva L, et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infectionJ Acquir Immune Defic Syndr 2003; 33: 349-55. (Pubitemid 36859061)
24. Republic of Indonesia National AIDS Commission. National action plan 2007-2009. Jakarta: National AIDS Commission, 2007.
25. Republic of Indonesia Ministry of Health. Mathematic model of HIV epidemic in Indonesia 2008-2014. Jakarta: Ministry of Health, 2008.
26. Sahbandar IN, Takahashi K, Djoerban Z, et al. Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia. AIDS Res Hum Retroviruses 2009; 25: 637-46.
27. Saphonn V, Parekh BS, Dobbs T, et al. Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999-2002J Acquir Immune Defic Syndr 2005; 39: 587-92. (Pubitemid 41098475)
28. Todd J, Lutalo T, Kaleebu P. Estimating incidence of HIV infection in Uganda. JAMA 2009; 301: 159-60.
29. Truong HM, Kellogg T, Klausner J, Dilley J, McFarland W. Recent HIV-1 infection detection: comparison of incidence estimates derived by laboratory assays and repeat testing dataJ Acquir Immune Defic Syndr 2009; 51: 502-5.
30. UNAIDS Reference Group on estimates, modeling and projections. Statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Wkly Epidemiol Rec 2006; 81: 40.